Evaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquine

British Journal of Ophthalmology

Volumn 94, Issue 12, 2010, Pages 1637-1642

  Bergholz, R ^a   Schroeter, J ^a   Ruther K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; FEMALE; GROUPS BY AGE; HUMAN; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETINA INJURY; RISK FACTOR; SMOKING; TOBACCO DEPENDENCE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; CHLOROQUINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LONG-TERM CARE; MALE; MIDDLE AGED; RETINA; RETINAL DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; VISUAL FIELDS; YOUNG ADULT;

EID: 78649835540     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.174458     Document Type: Article

References (21)

1. Yam JC, Kwok AK. Ocular toxicity of hydroxychloroquine. Hong Kong Med J 2006;12:294-304.
2. Marmor MF, Carr RE, Easterbrook M, et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 2002;109:1377-82.
3. Johnson MW, Vine AK. Hydroxychloroquine therapy in massive total doses without retinal toxicity. Am J Ophthalmol 1987;104:139-44.
4. Ruther K, Foerster J, Berndt S, et al. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses]. Ophthalmologe 2007;104:875-9.
5. Browning DJ. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity. Am J Ophthalmol 2002;133:649-56.
6. Easterbrook M. Current concepts in monitoring patients on antimalarials. Aust N Z J Ophthalmol 1998;26:101-3.
7. Levy GD, Munz SJ, Paschal J, et al. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum 1997;40:1482-6.
8. Marmor MF. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG. Am J Ophthalmol 2005;140:894-5.
9. Lai TY, Chan WM, Li H, et al. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol 2005;140:794-807.
10. Kellner U, Renner AB, Tillack H. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/ hydroxychloroquine. Invest Ophthalmol Vis Sci 2006;47:3531-8.
11. Kellner S, Weinitz S, Kellner U. Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol 2009;93:1444-7.
12. Pasadhika S, Fishman GA. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye 2009;24:340-6.
13. Voipio H. Incidence of chloroquine retinopathy. Acta Ophthalmol (Copenh) 1966;44:349-54.
14. Swaroop A, Chew EY, Bowes RC, et al. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009;10:19-43.
15. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease Study Report Number 3. Ophthalmology 2000;107:2224-32.
16. Vingerling JR, Hofman A, Grobbee DE, et al. Age-related macular degeneration and smoking. the rotterdam study. Arch Ophthalmol 1996;114:1193-6.
17. Araiza-Casillas R, Cardenas F, Morales Y, et al. Factors associated with chloroquine-induced retinopathy in rheumatic diseases. Lupus 2004;13:119-24.
18. Rynes RI, Krohel G, Falbo A, et al. Ophthalmologic safety of long-term hydroxychloroquine treatment. Arthritis Rheum 1979;22:832-6.
19. Tobin DR, Krohel G, Rynes RI. Hydroxychloroquine. seven-year experience. Arch Ophthalmol 1982;100:81-3.
20. Bernstein HN. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy. Am J Med 1983;75:25-34.
21. Shroyer NF, Lewis RA, Lupski JR. Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? Am J Ophthalmol 2001;131:761-6.